Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul>
<li>Lagercrantz Group's latest reported results highlight both strengths and challenges within their business operations, offering a balanced perspective on their performance and future outlook.</li>
<li>Positively, Lagercrantz demonstrated robust financial metrics over the past year.</li>
<li>Net revenues increased by 16%, buoyed by a strong acquisition strategy that contributed 14% to growth, while organic growth, though moderate, stood at 2%.</li>
</ul>


Lagercrantz Group's latest reported results highlight both strengths and challenges within their business operations, offering a balanced perspective on their performance and future outlook.
Positively, Lagercrantz demonstrated robust financial metrics over the past year.
Net revenues increased by 16%, buoyed by a strong acquisition strategy that contributed 14% to growth, while organic growth, though moderate, stood at 2%.


Index Rebal Trades & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal Trades & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

Samhällsbyggnadsbolaget I Norden AB / Index Rebalance

<ul>
<li>The June 2023 regular rebalance index changes for the SE600 index and the EURSTX index were announced after the close yesterday.</li>
<li>There are 8 ADDs/DELs for the SE600 index and 3 ADDs and 2 DELs for the EURSTX index.</li>
<li>In this insight, we take a closer look at our final index flow expectations for June 2023.</li>
</ul>


The June 2023 regular rebalance index changes for the SE600 index and the EURSTX index were announced after the close yesterday.
There are 8 ADDs/DELs for the SE600 index and 3 ADDs and 2 DELs for the EURSTX index.
In this insight, we take a closer look at our final index flow expectations for June 2023.


SE600 Jun 23 Rebal: Past Trades Successful, DELs Could Underperform Index over the Next ~2 Weeks

Event-Driven

<ul>
<li>In this insight, we take a look at the names leading the race to become ADDs/DELs for the STX Europe 600 and EUROSTX Indices for the June 2023 Rebalance.</li>
<li>I currently expect <a href="https://www.smartkarma.com/entities/credit-suisse-group-ag-f4b24f0c-c294-40b3-b491-759f0cb277e9" target="_blank" data-smartkarma-citation="entities:27915:1" rel="noopener">Credit Suisse (CSGN SW)</a> and <a href="https://www.smartkarma.com/entities/al-noor-hospitals-group-plc" target="_blank" data-smartkarma-citation="entities:21813:1" rel="noopener">Mediclinic International (MDC LN)</a> to be deleted in the next few trading days</li>
<li>Separately, there could be five ADDs and DELs during the regular review in June 2023.</li>
</ul>


In this insight, we take a look at the names leading the race to become ADDs/DELs for the STX Europe 600 and EUROSTX Indices for the June 2023 Rebalance.
I currently expect Credit Suisse (CSGN SW) and Mediclinic International (MDC LN) to be deleted in the next few trading days
Separately, there could be five ADDs and DELs during the regular review in June 2023.


Quiddity Leaderboard SE600 Jun 23: Credit Suisse Deletion Imminent; Multiple Changes in June

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>Risk-on signals continue to pile up, which continues to support our constructive outlook. Building off of last week's report, growth Sectors such as Technology and Communications continue to improve and we recommend adding exposure (e.g., Bilibili BILI-US/9626-HK).</p>

Risk-on signals continue to pile up, which continues to support our constructive outlook. Building off of last week's report, growth Sectors such as Technology and Communications continue to improve and we recommend adding exposure (e.g., Bilibili BILI-US/9626-HK).

Global Equity Strategy: Growth Sectors Continue To Improve -- Add Exposure

Sweden

Lagercrantz Group AB sells products and solutions in the fields of electronics and communications. The Company's product line includes special components and modules, wiring harnesses, as well as products and solutions in security and communication. Lagercrantz sells and markets to manufacturing companies mainly in northern Europe.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lagercrantz Group Ab (LAGRB SS)

Lagercrantz Group - Crushing Overheads

Lagercrantz Group's latest reported results highlight both strengths and challenges within their business operations, offering a balanced...

Baptista Research

SE600 Jun 23 Rebal: Past Trades Successful, DELs Could Underperform Index over the Next ~2 Weeks

The changes are mostly in line with expectations. SE600 and EURSTX DELs have historically managed to underperform the SE600 index on average from...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard SE600 Jun 23: Credit Suisse Deletion Imminent; Multiple Changes in June

The rankings for the June 2023 review will be based on float market caps as at the close of trading on 31st May 2023. The Top 5 Potential ADDs...

Janaghan Jeyakumar, CFA

Global Equity Strategy: Growth Sectors Continue To Improve -- Add Exposure

Building off of last week's report, growth Sectors such as Technology and Communications continue to improve and we recommend adding exposure...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)